Phase 3 Alzheimer's Disease Trial, By Invitation NCT06194799 Sponsor: ACADIA Pharmaceuticals Inc. Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 3 Alzheimer's Disease Trial, By Invitation

NCT06194799
By Invitation Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have successfully completed the ACP-204-006 study.
  • People aged 55 to 95 years old; women must not be able to become pregnant, and men must use appropriate contraception if their partner could become pregnant.
  • People who have a designated study partner or caregiver.
  • People who are able to attend all required study visits together with their study partner or caregiver.
  • People who have signed an informed consent form, along with a caregiver or legal representative.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who need to take a medication that is not permitted under the study protocol.
  • People who are in hospice care, receiving end-of-life palliative care, or who have become bedridden.
  • People who have an unstable and significant medical condition other than Alzheimer's disease.
  • People who have any medical condition that the study doctor believes could affect their safety or their ability to complete the study.
  • Additional criteria may apply, and the trial site will assess each person during a screening process to confirm whether all requirements for participation are met.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 18 August 2026

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Phase 3
Sponsor
ACADIA Pharmaceuticals Inc.
Registry
ClinicalTrials.gov
Start date
23 April 2024
Est. completion
1 April 2029

Where this trial is recruiting

🇧🇷 Brazil 🇧🇬 Bulgaria 🇨🇱 Chile 🇨🇿 Czechia 🇫🇷 France 🇮🇹 Italy 🇲🇽 Mexico 🇷🇸 Serbia 🇰🇷 South Korea 🇪🇸 Spain 🇹🇼 Taiwan 🇺🇸 United States

Primary endpoints

Treatment-emergent adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov